Plasminogen activators play an essential role in extracellular-matrix invasion by lymphoblastic T cells

International Journal of Cancer

Volumn 70, Issue 4, 1997, Pages 461-466

  Reiter, Lars S ^a   Spertini, Olivier ^a   Kruithof, Egbert K O ^a,b,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Kantonsspital Frauenfeld   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CELL INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T CELL LEUKEMIA;

ANTIGENS, CD; HUMANS; LEUKEMIA, T-CELL; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PLASMINOGEN ACTIVATORS; TISSUE PLASMINOGEN ACTIVATOR; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031025629     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970207)70:4<461::AID-IJC14>3.0.CO;2-I     Document Type: Article

References (22)

1. ALIZADEH, H., MA, D., HERMAN, M., BELLINGHAM, D., COMERFORD, S.A., GETHING, M.J.H., SAMBROOK, J.F. and NIEDERKORN, J.Y., Tissue-type plasminogen activator-induced invasion and metastasis of murine melanomas. Curr. Eye Res., 14, 449-458 (1995).
2. CONESE, M. and BLASI, F., The urokinase/urokinase-receptor system and cancer invasion. Baillieres clin. Haematol., 8, 365-389 (1995).
3. CROWLEY, C.W., COHEN, R.L., LUCAS, B.K., Liu, G., SHUMAN, M.A. and LEVINSON, A.D., Prevention of metastasis by inhibition of the urokinase receptor. Proc. nat. Acad. Sci. (Wash.). 90, 5021-5025 (1993).
4. DE CLERCK, Y.A., FEREZ, N., SHIMADA, H., BOONE, T.C., LANGLEY, K.E. and TAYLOR, S.M., Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res., 52, 701-708 (1992).
5. HAJJAR, K.A., Cellular receptors in the regulation of plasmin generation. Thromb. Haemost., 74, 294-301 (1995).
6. MEISSAUER, A., KRAMER, M.D., HOFMANN, M., ERKELL, L.J., JACOB, E., SCHIRRMACHER, V. and BRUNNER, G., Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp. Cell Res., 192, 453-459 (1991).
7. MIGNATTI, P. and RIFKIN, D.B., Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73, 161-195 (1993).
8. MONAHAM, S., SAWAYA, R., MCCUTCHEON, L., ALI-OSMAN, F., BOYD, D. and RAO, J.S., Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminoeen-activator-receptor antibody. Cancer Res., 53, 4143-1147 (1993).
9. MUELLER, B.M., Yu, Y.B. and LAUG, W.E., Over-expression of plasminogen-activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in SCID/SCID mice. Proc. nat. Acad. Sci. (Wash.), 92, 205-209 (1995).
10. ORTEGA, J.A., NESBIT, M.E., SATHER, H.N., ROBINSON, L.L., D'ANGIO, G.J. and HAMMOND, G.D., Long-term evaluation of a CNS prophylaxis trialtreatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group. J. din. Oncol., 5, 1646-1654 (1987).
11. PINKEL, D. and Woo, S., Prevention and treatment of meningeal leukemia in children. Blood, 84, 355-366 (1994).
12. QUATTRONE, A., FIBBI, G., ANICHINI, E., PUCCI, M., ZAMPERINI, A,. CAPACCIOLI, S. and DEL Rosso, M., Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase-receptor-gene expression. Cancer Res., 55, 90-95 (1995).
13. REITER, L.S., KRUITHOF, E.K.O., CAJOT, J.F. and SORDAT, B., The role of the urokinase receptor in extracellular-matrix degradation by HT29 human colon-carcinoma cells. Int. J. Cancer, 53, 444-450 (1993).
14. REPESH, L.A., A new in vitro assay for quantitating tumor-cell invasion. Invasion Metastasis, 9, 192-208 (1989).
15. RUCKLIDGE, G.J., EDVARDSEN, K. and BOCK, E., Cell-adhesion molecules and metalloproteinases: a linked role in tumour-cell invasiveness. Biochem. Soc. Trans., 22, 63-68 (1994).
16. SCHERRER, A., KRUITHOF, E.K.O. and GRUB, J.P., Plasminogen activator inhibitor 2 in patients with monocytic leukemia. Leukemia, 5, 479-486 (1991).
17. SPERTINI, O., KANSAS, G.S., REIMANN, K.A., MACKAY, C.R. and TEDDER, T.F., Function and evolutionary conservation of distinct epitopes on the leukocyte adhesion molecule-1 (TQ-1, Leu-8) that regulate leukocyte migration. J. Immunol., 147, 942-949 (1991).
18. STETLER-STEVENSON, W.G., AZNAVOORIAN, S. and LIOTTA, L.A., Tumor-cell interactions with the extracellular matrix during invasion and metastasis. Ann. Rev. Cell Biol., 9, 541-573 (1993).
19. VAN DEN ElJNDEN-SCHRAUWEN, Y., KOOISTRA, T., DE VRIES, R.E.M. and EMEIS, J.J., Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood, 85, 3510-3517 (1995).
20. WILHELM, O., WEIDLE, U., HOHL, S., RETTENBERGER, P., SCHMITT, M. and GRAEFF, H., Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (u-PA). Inhibition of proliferation and invasion of human ovarian-cancer cells. FEBS Lett., 337, 131-134 (1994).
21. WILSON, E.L. and FRANCIS, G.E., Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells. J. exp. Med., 165, 1609-1623 (1987).
22. WILSON, E.L., JACOBS, P. and DOWDLE, E.B., The secretion of plasminogen activators by human myeloid leukemic cells in vitro. Blood, 61, 568-574 (1983).